{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T13:56:29Z","timestamp":1781618189098,"version":"3.54.5"},"reference-count":73,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T00:00:00Z","timestamp":1778544000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000521","name":"Canadian Cancer Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000521","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009395","name":"Cancercare Manitoba Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009395","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009326","name":"Cancer Research Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009326","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008794","name":"Research Manitoba","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013500","name":"Canadian Cardiovascular Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013500","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017552","name":"University of Manitoba Max Rady College of Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017552","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000147","name":"Canadian Cancer Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000147","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000238","name":"Brain Tumour Foundation of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000238","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.bbrc.2026.153934","type":"journal-article","created":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T23:20:53Z","timestamp":1778628053000},"page":"153934","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["TP63 expression correlates with mesenchymal-like gene signature in patient-derived recurrent glioblastoma cells"],"prefix":"10.1016","volume":"823","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-3985-0703","authenticated-orcid":false,"given":"Emma","family":"Martell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-5260-349X","authenticated-orcid":false,"given":"Helgi","family":"Kuzmychova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akaljot","family":"Grewal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ujala","family":"Chawla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charul","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chitra","family":"Venugopal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher M.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1272-5300","authenticated-orcid":false,"given":"Sheila K.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanveer","family":"Sharif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2026.153934_bib1","first-page":"381","article-title":"Brain and other central nervous system tumor statistics, 2021","volume":"71","author":"Miller","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.bbrc.2026.153934_bib2","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/neuonc\/nos273","article-title":"Standards of care for treatment of recurrent glioblastoma--are we there yet?","volume":"15","author":"Weller","year":"2013","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.bbrc.2026.153934_bib3","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1001\/jama.2017.18718","article-title":"Effect of tumor-treating fields plus maintenance temozolomide vs maintenance temozolomide alone on survival in patients with glioblastoma: a randomized clinical trial","volume":"318","author":"Stupp","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.bbrc.2026.153934_bib4","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma","volume":"352","author":"Stupp","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbrc.2026.153934_bib5","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S1470-2045(09)70025-7","article-title":"Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial","volume":"10","author":"Stupp","year":"2009","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.bbrc.2026.153934_bib6","series-title":"Glioblastoma","article-title":"Current standards of care in glioblastoma therapy","author":"Fernandes","year":"2017"},{"key":"10.1016\/j.bbrc.2026.153934_bib7","doi-asserted-by":"crossref","DOI":"10.6061\/clinics\/2020\/e1553","article-title":"Patterns of recurrence and outcomes of glioblastoma multiforme treated with chemoradiation and adjuvant temozolomide","volume":"75","author":"Faustino","year":"2020","journal-title":"Clinics (Sao Paulo)"},{"key":"10.1016\/j.bbrc.2026.153934_bib8","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1200\/JCO.2008.19.4969","article-title":"Recurrence pattern after temozolomide concomitant with and adjuvant to radiotherapy in newly diagnosed patients with glioblastoma: correlation with MGMT promoter methylation status","volume":"27","author":"Brandes","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bbrc.2026.153934_bib9","doi-asserted-by":"crossref","first-page":"30968","DOI":"10.18632\/oncotarget.5038","article-title":"Comprehensive portrait of recurrent glioblastoma multiforme in molecular and clinical characteristics","volume":"6","author":"Li","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbrc.2026.153934_bib10","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1038\/s43018-022-00475-x","article-title":"A single-cell atlas of glioblastoma evolution under therapy reveals cell-intrinsic and cell-extrinsic therapeutic targets","volume":"3","author":"Wang","year":"2022","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.bbrc.2026.153934_bib11","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ccr.2009.12.020","article-title":"Genome Atlas Research, Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1","volume":"17","author":"Verhaak","year":"2010","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbrc.2026.153934_bib12","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ccr.2013.08.001","article-title":"Mesenchymal differentiation mediated by NF-kappaB promotes radiation resistance in glioblastoma","volume":"24","author":"Bhat","year":"2013","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbrc.2026.153934_bib13","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1093\/neuonc\/nos158","article-title":"Glioblastoma resistance to anti-VEGF therapy is associated with myeloid cell infiltration, stem cell accumulation, and a mesenchymal phenotype","volume":"14","author":"Piao","year":"2012","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.bbrc.2026.153934_bib14","doi-asserted-by":"crossref","DOI":"10.3390\/genes14030651","article-title":"EGFRvIII promotes the proneural-mesenchymal transition of glioblastoma multiforme and reduces its sensitivity to temozolomide by regulating the NF-kappaB\/ALDH1A3 axis","volume":"14","author":"Shi","year":"2023","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.bbrc.2026.153934_bib15","article-title":"Machine learning and multi-omics analysis reveal key regulators of proneural-mesenchymal transition in glioblastoma","volume":"15","author":"Xu","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbrc.2026.153934_bib16","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1016\/j.cell.2022.04.038","article-title":"Glioma progression is shaped by genetic evolution and microenvironment interactions","volume":"185","author":"Varn","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.bbrc.2026.153934_bib17","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1038\/s41588-025-02168-4","article-title":"Deciphering the longitudinal trajectories of glioblastoma ecosystems by integrative single-cell genomics","volume":"57","author":"Spitzer","year":"2025","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbrc.2026.153934_bib18","article-title":"Multiomics profiling of paired primary and recurrent glioblastoma patient tissues","volume":"2","author":"Dekker","year":"2020","journal-title":"Neurooncol.Adv."},{"key":"10.1016\/j.bbrc.2026.153934_bib19","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.ccell.2023.12.015","article-title":"Integrated proteogenomic characterization of glioblastoma evolution","volume":"42","author":"Kim","year":"2024","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbrc.2026.153934_bib20","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.cell.2019.06.024","article-title":"An integrative model of cellular States, plasticity, and genetics for glioblastoma","volume":"178","author":"Neftel","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.bbrc.2026.153934_bib21","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1038\/s41467-019-09853-z","article-title":"Stem cell-associated heterogeneity in Glioblastoma results from intrinsic tumor plasticity shaped by the microenvironment","volume":"10","author":"Dirkse","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbrc.2026.153934_bib22","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1093\/neuonc\/noae044","article-title":"Identification of transcriptomic signatures associated with glioblastoma recurrence","volume":"26","author":"Lawler","year":"2024","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.bbrc.2026.153934_bib23","article-title":"Adapt to persist: glioblastoma microenvironment and epigenetic regulation on cell plasticity","volume":"11","author":"Uribe","year":"2022","journal-title":"Biology (Basel)"},{"key":"10.1016\/j.bbrc.2026.153934_bib24","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1038\/s41588-025-02167-5","article-title":"The multilayered transcriptional architecture of glioblastoma ecosystems","volume":"57","author":"Nomura","year":"2025","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbrc.2026.153934_bib25","doi-asserted-by":"crossref","DOI":"10.3390\/cancers10090297","article-title":"The p53 pathway in glioblastoma","volume":"10","author":"Zhang","year":"2018","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bbrc.2026.153934_bib26","doi-asserted-by":"crossref","first-page":"285","DOI":"10.3389\/fonc.2014.00285","article-title":"p53 family and cellular stress responses in cancer","volume":"4","author":"Pflaum","year":"2014","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbrc.2026.153934_bib27","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1158\/1541-7786.371.2.7","article-title":"p63 and p73: roles in development and tumor formation","volume":"2","author":"Moll","year":"2004","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.bbrc.2026.153934_bib28","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1038\/nature07385","article-title":"Comprehensive genomic characterization defines human glioblastoma genes and core pathways","volume":"455","author":"Cancer Genome Atlas Research","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2026.153934_bib29","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s11060-019-03318-5","article-title":"The role of TP53 gain-of-function mutation in multifocal glioblastoma","volume":"147","author":"Olafson","year":"2020","journal-title":"J. Neuro Oncol."},{"key":"10.1016\/j.bbrc.2026.153934_bib30","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1038\/s41419-022-05408-1","article-title":"Mutant p53 in cancer: from molecular mechanism to therapeutic modulation","volume":"13","author":"Chen","year":"2022","journal-title":"Cell Death Dis."},{"issue":"Pt 10","key":"10.1016\/j.bbrc.2026.153934_bib31","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1242\/jcs.113.10.1661","article-title":"The p53\/p63\/p73 family of transcription factors: overlapping and distinct functions","volume":"113","author":"Levrero","year":"2000","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.bbrc.2026.153934_bib32","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.ccr.2005.02.019","article-title":"Tumor predisposition in mice mutant for p63 and p73: evidence for broader tumor suppressor functions for the p53 family","volume":"7","author":"Flores","year":"2005","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbrc.2026.153934_bib33","doi-asserted-by":"crossref","first-page":"11785","DOI":"10.18632\/oncotarget.7600","article-title":"p73 promotes glioblastoma cell invasion by directly activating POSTN (periostin) expression","volume":"7","author":"Landre","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbrc.2026.153934_bib34","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a004887","article-title":"p63 and p73, the ancestors of p53","volume":"2","author":"Dotsch","year":"2010","journal-title":"Cold Spring Harbor Perspect. Biol."},{"key":"10.1016\/j.bbrc.2026.153934_bib35","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1158\/1078-0432.CCR-17-3177","article-title":"TAp73 modifies metabolism and positively regulates growth of cancer stem-like cells in a redox-sensitive manner","volume":"25","author":"Sharif","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbrc.2026.153934_bib36","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/978-94-017-9211-0_2","article-title":"Alterations of p63 and p73 in human cancers","volume":"85","author":"Inoue","year":"2014","journal-title":"Subcell. Biochem."},{"key":"10.1016\/j.bbrc.2026.153934_bib37","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s12307-012-0116-9","article-title":"Role of p63 in development, tumorigenesis and cancer progression","volume":"5","author":"Bergholz","year":"2012","journal-title":"Cancer Microenviron."},{"key":"10.1016\/j.bbrc.2026.153934_bib38","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1038\/sj.emboj.7600708","article-title":"TAp63alpha induces apoptosis by activating signaling via death receptors and mitochondria","volume":"24","author":"Gressner","year":"2005","journal-title":"EMBO J."},{"key":"10.1016\/j.bbrc.2026.153934_bib39","doi-asserted-by":"crossref","first-page":"7589","DOI":"10.1158\/0008-5472.CAN-06-2020","article-title":"Loss of p63 leads to increased cell migration and up-regulation of genes involved in invasion and metastasis","volume":"66","author":"Barbieri","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbrc.2026.153934_bib40","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1038\/ncb1988","article-title":"TAp63 induces senescence and suppresses tumorigenesis in vivo","volume":"11","author":"Guo","year":"2009","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.bbrc.2026.153934_bib41","doi-asserted-by":"crossref","first-page":"15312","DOI":"10.1073\/pnas.1110977109","article-title":"Loss of p63 and its microRNA-205 target results in enhanced cell migration and metastasis in prostate cancer","volume":"109","author":"Tucci","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbrc.2026.153934_bib42","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ccr.2005.12.013","article-title":"p63 mediates survival in squamous cell carcinoma by suppression of p73-dependent apoptosis","volume":"9","author":"Rocco","year":"2006","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbrc.2026.153934_bib43","doi-asserted-by":"crossref","first-page":"9362","DOI":"10.1158\/0008-5472.CAN-06-1619","article-title":"Tumor-specific p73 up-regulation mediates p63 dependence in squamous cell carcinoma","volume":"66","author":"DeYoung","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbrc.2026.153934_bib44","doi-asserted-by":"crossref","first-page":"5462","DOI":"10.1073\/pnas.97.10.5462","article-title":"AIS is an oncogene amplified in squamous cell carcinoma","volume":"97","author":"Hibi","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbrc.2026.153934_bib45","first-page":"7113","article-title":"Significance of p63 amplification and overexpression in lung cancer development and prognosis","volume":"63","author":"Massion","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbrc.2026.153934_bib46","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1038\/onc.2015.230","article-title":"p63 controls cell migration and invasion by transcriptional regulation of MTSS1","volume":"35","author":"Giacobbe","year":"2016","journal-title":"Oncogene"},{"key":"10.1016\/j.bbrc.2026.153934_bib47","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1038\/s41419-025-07938-w","article-title":"TP63 as a modulator of ferroptosis in TP53 mutations glioblastoma","volume":"16","author":"Cai","year":"2025","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbrc.2026.153934_bib48","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1158\/0008-5472.CAN-17-1803","article-title":"Distinct TP63 isoform-driven transcriptional signatures predict tumor progression and clinical outcomes","volume":"78","author":"Abbas","year":"2018","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbrc.2026.153934_bib49","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ccell.2016.12.001","article-title":"ACTL6A is Co-Amplified with p63 in squamous cell carcinoma to drive YAP activation, regenerative proliferation, and poor prognosis","volume":"31","author":"Saladi","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbrc.2026.153934_bib50","doi-asserted-by":"crossref","first-page":"3499","DOI":"10.1073\/pnas.1500762112","article-title":"p63 sustains self-renewal of mammary cancer stem cells through regulation of Sonic Hedgehog signaling","volume":"112","author":"Memmi","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbrc.2026.153934_bib51","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1093\/neuonc\/noaf008","article-title":"Disease stage-specific role of the mitochondrial pyruvate carrier suppresses differentiation in temozolomide and radiation-treated glioblastoma","volume":"27","author":"Martell","year":"2025","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.bbrc.2026.153934_bib52","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s11060-015-1951-6","article-title":"A novel stem cell culture model of recurrent glioblastoma","volume":"126","author":"Qazi","year":"2016","journal-title":"J. Neuro Oncol."},{"key":"10.1016\/j.bbrc.2026.153934_bib53","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-026-08646-9","article-title":"Glioblastoma cells that evade chemoradiotherapy-induced cell death exhibit a bifurcated glycolytic program","volume":"17","author":"Martell","year":"2026","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbrc.2026.153934_bib54","article-title":"Identification of five important genes to predict glioblastoma subtypes","volume":"3","author":"Tang","year":"2021","journal-title":"Neurooncol.Adv."},{"key":"10.1016\/j.bbrc.2026.153934_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111420","article-title":"Characterization of the minimal residual disease state reveals distinct evolutionary trajectories of human glioblastoma","volume":"40","author":"Qazi","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/j.bbrc.2026.153934_bib56","doi-asserted-by":"crossref","first-page":"2936","DOI":"10.1038\/s41591-024-03138-9","article-title":"Targeting axonal guidance dependencies in glioblastoma with ROBO1 CAR T cells","volume":"30","author":"Chokshi","year":"2024","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbrc.2026.153934_bib57","unstructured":"T.H.P. Atlas, The Human Protein Atlas, proteinatlas.org."},{"key":"10.1016\/j.bbrc.2026.153934_bib58","doi-asserted-by":"crossref","DOI":"10.3390\/cells13110942","article-title":"The role of mesenchymal reprogramming in malignant clonal evolution and intra-tumoral heterogeneity in glioblastoma","volume":"13","author":"Wu","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.bbrc.2026.153934_bib59","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/nbt1385","article-title":"Direct multiplexed measurement of gene expression with color-coded probe pairs","volume":"26","author":"Geiss","year":"2008","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.bbrc.2026.153934_bib60","doi-asserted-by":"crossref","first-page":"3371","DOI":"10.1038\/s41388-023-02859-4","article-title":"p63: a crucial player in epithelial stemness regulation","volume":"42","author":"Li","year":"2023","journal-title":"Oncogene"},{"key":"10.1016\/j.bbrc.2026.153934_bib61","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/978-1-4939-8805-1_7","article-title":"In vitro self-renewal assays for brain tumor stem cells","volume":"1869","author":"Seyfrid","year":"2019","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.bbrc.2026.153934_bib62","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13010047","article-title":"Recurrent glioblastoma: from molecular landscape to new treatment perspectives","volume":"13","author":"Birzu","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bbrc.2026.153934_bib63","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1093\/neuonc\/noab269","article-title":"Cancer cell heterogeneity and plasticity: a paradigm shift in glioblastoma","volume":"24","author":"Yabo","year":"2022","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.bbrc.2026.153934_bib64","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/s41392-021-00491-w","article-title":"The adaptive transition of glioblastoma stem cells and its implications on treatments","volume":"6","author":"Wang","year":"2021","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.bbrc.2026.153934_bib65","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1093\/neuonc\/nox119","article-title":"Targeting the mesenchymal subtype in glioblastoma and other cancers via inhibition of diacylglycerol kinase alpha","volume":"20","author":"Olmez","year":"2018","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.bbrc.2026.153934_bib66","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14153747","article-title":"CD44 depletion in glioblastoma cells suppresses growth and stemness and induces senescence","volume":"14","author":"Kolliopoulos","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bbrc.2026.153934_bib67","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/s41419-025-07617-w","article-title":"Temozolomide promotes glioblastoma stemness expression through senescence-associated reprogramming via HIF1alpha\/HIF2alpha regulation","volume":"16","author":"Wang","year":"2025","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbrc.2026.153934_bib68","doi-asserted-by":"crossref","first-page":"274","DOI":"10.4161\/cc.6.3.3797","article-title":"TAp63 and DeltaNp63 in cancer and epidermal development","volume":"6","author":"Candi","year":"2007","journal-title":"Cell Cycle"},{"key":"10.1016\/j.bbrc.2026.153934_bib69","doi-asserted-by":"crossref","first-page":"e165","DOI":"10.1002\/ctm2.165","article-title":"DeltaNp63 drives epithelial differentiation in glioma","volume":"10","author":"Lu","year":"2020","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.bbrc.2026.153934_bib70","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/s41389-018-0073-3","article-title":"DeltaNp63 regulates the expression of hyaluronic acid-related genes in breast cancer cells","volume":"7","author":"Gatti","year":"2018","journal-title":"Oncogenesis"},{"key":"10.1016\/j.bbrc.2026.153934_bib71","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1038\/sj.onc.1205330","article-title":"TAp63gamma (p51A) and dNp63alpha (p73L), two major isoforms of the p63 gene, exert opposite effects on the vascular endothelial growth factor (VEGF) gene expression","volume":"21","author":"Senoo","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.bbrc.2026.153934_bib72","doi-asserted-by":"crossref","first-page":"4325","DOI":"10.1007\/s00018-020-03539-2","article-title":"TP63 links chromatin remodeling and enhancer reprogramming to epidermal differentiation and squamous cell carcinoma development","volume":"77","author":"Yi","year":"2020","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.bbrc.2026.153934_bib73","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1038\/srep01160","article-title":"Temozolomide suppresses MYC via activation of TAp63 to inhibit progression of human glioblastoma","volume":"3","author":"Yamaki","year":"2013","journal-title":"Sci. Rep."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X26006984?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X26006984?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T13:06:43Z","timestamp":1781615203000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X26006984"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":73,"alternative-id":["S0006291X26006984"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2026.153934","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"TP63 expression correlates with mesenchymal-like gene signature in patient-derived recurrent glioblastoma cells","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2026.153934","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"153934"}}